# Cellular and immune landscape of chronic liver diseases: insights from immunophenotyping

## TL;DR

This study compares immune cell profiles in different types of chronic liver disease and finds distinct patterns that could inform future treatments.

## Contribution

The study provides novel insights into immune cell differences between alcohol-related and viral liver diseases and their implications for hepatocellular carcinoma.

## Key findings

- Patients with viral hepatitis and peri-tumor samples had higher hepatic B cell counts compared to those with alcohol-related liver disease.
- Chronic liver disease patients showed higher levels of CD57+ T cells, indicating T cell differentiation.
- Peri-tumor liver specimens had lower NK cell counts and upregulated TIGIT, suggesting increased immune inhibition.

## Abstract

Chronic liver disease due to alcohol-related liver disease and chronic viral hepatitis pose a substantial burden on healthcare systems. Chronic liver disease may predispose to hepatocellular carcinoma, for which therapeutic options are limited. This study aimed to explore the immune cell characteristics of the clinical conditions.

Explant liver samples were collected from 25 patients for bulk RNA sequencing and flow cytometry analysis. Immune cell populations were characterized by flow cytometry from isolated hepatic and peripheral mononuclear cells.

Significant differences in immune cell characteristics were observed among patients with three clinical conditions. Viral hepatitis and peri-tumor samples exhibited higher hepatic B cell counts compared to alcohol-related liver disease. Additionally, chronic liver disease patients showed higher levels of CD57+ T cells, suggestive of T cell differentiation. Differential expression analysis identified several genes associated with immune regulation, including downregulation of CD27 and upregulation of granzyme B in ARLD, consistent with a highly differentiated phenotype. LAG3 and PDCD1 were upregulated in peri-tumor samples. The NK cell count was lower in peri-tumor liver specimens compared to ARLD, and an upregulation of TIGIT, an inhibitory marker, was observed in those peri-tumor specimens.

This study contributes to the understanding of immune dynamics in chronic liver disease among different etiologies. B lymphocytes are relatively reduced in alcohol-related liver disease compared to other groups, and T cells exhibit a more differentiated subtype. The peritumor microenvironment in HCC suggests a relatively diminished presence of NK cells and a potential tendency toward increased inhibitory characteristics.